Diabetic nephropathy in 2014: Improved cardiorenal prognosis in diabetic nephropathy

Nature Reviews Nephrology 11, 68 (2015). doi:10.1038/nrneph.2014.238 Authors: Hans-Henrik Parving & Peter Rossing In 2014, key studies in the field of diabetic nephropathy highlighted the importance of albuminuria as a predictor of cardiovascular risk and showed that the incidence of renal and cardiovascular complications is decreasing. Promising efficacy data were obtained with atrasentan, whereas a trial of bardoxolone methyl led to safety concerns.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Year in Review Source Type: research